- An Interview with Carl Mansfield, MD, ScD, FASTRO
Dr. Carl Mansfield began his medical career at Howard University in 1952. His postgraduate training began in diagnostic radiology, but his path changed with a rotation in radiation therapy with Dr. Simon Kramer at Jefferson University, where he saw cancer patients who were “alive and well five and ten years after treatment” which sold him on radiation oncology. He spent a year with Dr. Kramer in radiation therapy, another year in radiation oncology in England, then returned to Jefferson for two more years of training in pediatric radiation oncology. He served on faculty at Jefferson, took a chairmanship at the University of Kansas, then returned to Jefferson as chairman on Dr. Kramer’s retirement. Later he retired, but returned to active practice to head the radiation oncology division of the NCI, and, afterwards, to serve as chairman of the University of Maryland. His career has seen many changes—the technology evolution from orthovoltage to cobalt to linear accelerators and ultimately intensity modulated radiation therapy; the diagnostic evolution from clinical evaluations based on physical findings to reliance on diagnostic imaging with CT, MR, and PET; the evolution in cancer therapy decision making from solo surgeons or radiation oncologists doctors to the oncology team approach with collaborating medical and surgical oncologists; the evolution in our understanding of cancer origins and controls brought by radiation and molecular biology. Through his career, he has contributed to all aspects of radiation oncology as a mentor for the training of many physicians and physicists in radiation oncology, an innovator in brachytherapy and IMRT, a leader in breast cancer and lymphoma research both within his institutions and through cooperative group efforts. He has broken minority barriers in radiation oncology and been honored by the American Cancer Society for his longstanding efforts, particularly in the area of access and education for African American cancer patients.
- An Interview with Carl Robert Bogardus, MD, FASTRO
Carl Bogardus, MD, FASTRO, was born in Hyden, Ky. His father was a general practitioner in this rural southeastern Kentucky town, and Dr. Bogardus often went with his father on house calls to assist him, even at an early age. After attending Hanover College and then medical school at the University of Louisville. While in medical school, he worked in the newly formed nuclear medicine department with Dr. Pat Cavanagh, who encouraged him to go into radiation therapy and helped him secure a residency at Penrose Cancer Hospital with Dr. Juan Del Regato. Residency was followed by a fellowship at Mallinckrodt Institute of Radiology, where he worked with Drs. Bill Powers and Carlos Perez. His first faculty job was at the University of Oklahoma, where he worked with Dr. Sy Levitt. Dr. Bogardus later became president of ASTRO and later the ACR. He was instrumental in developing radiation oncology billing codes and dealing with the Relative Value System federal mandate.
- An Interview with Carl von Essen, MD
Carl von Essen, MD, was born in Tokyo, Japan, where his father was a Swedish diplomat. Subsequently his father was transferred to San Francisco were the family settled. Dr. von Essen obtained his undergraduate degree from the University of California at Berkeley and his medical school degree from Stanford University. He went to The University of Chicago Clinics to do his internship and subsequently to the Michael Reese Hospital for training in radiation oncology. He was drafted during the Korean War and following this he did a research fellowship at Stanford with Dr. Henry Kaplan. Later on Carl served on the faculty at several prestigious institutions. He was very involved with research and the clinical application of the combination of chemotherapy and radiation, the use of heavy particles and other innovative treatments. Carl also traveled and worked in different countries all over the world. He worked very hard and under very difficult circumstances to improve the standards of cancer care and in particular of radiation oncology.
- An Interview with Chu Chang, MD, FASTRO
Chu Huai Chang, M.D. was born in the Fujian province of China in 1917, and he graduated from the St. John’s Medical School in Shanghai in 1944. He came to the United States on a Donner Foundation Fellowship in 1947. He initially served as a fellow in medicine and then later a fellow in radiology under the direction of Robert S. Stone, chairman of the department of radiology at the University of California. Dr. Chang then served as a radiology resident at the Jersey City Medical Center before joining the anatomy department as a fellow in 1950. He progressed through the ranks at Yale, as an instructor in 1951, an assistant professor in radiology in 1954. He moved to Columbia University in 1962 as associate professor in 1967, and he served as chief of radiotherapy at Columbia-Presbyterian Hospital from 1970 to 1984.
- An Interview with David H. Hussey, MD, FASTRO
An Interview with David H. Hussey, MD, FASTRO
Question: The date is the 12 of June of 2012, and this is Chris Rose. Dave Larson and I will be interviewing Dave Hussey. For the record, Drs. Rose, Hussey and Larson were ASTRO presidents beginning in 1998, 1999 and 2000, respectively. Are you all set, Dave? D
- An Interview with Eleanor Montague, MD
Eleanor Montague, MD, and her parents emigrated from Italy to Pennsylvania prior to World War II. She graduated from the University of Alabama and the Women’s Medical School of Pennsylvania in Philadelphia. She interned at Kings County in Brooklyn, and her radiation oncology residency was with Morton Kligerman at Columbia. Dr. Montague did diagnostic radiology in Japan while her husband served there. Later they both joined the MD Anderson staff. Working with G.H. Fletcher, Dr. Montague became an international authority on the treatment of breast cancer.
- An Interview with Eli Glatstein, MD, FASTRO
Dr. Eli Glatstein was born and raised in Muscatine, a small Iowa town where his father owned a furniture store. After completing his undergraduate studies at the University of Iowa, he went to medical school at Stanford where he came in contact with Henry Kaplan and Malcom Bagshaw who influenced him on his specialty choice and professional career.
After he completed his residency at Stanford, he spent two years at Hammersmith Hospital and the Gray Laboratory in England, doing research and then fulfilled his military obligation in South Vietnam before returning to Stanford as a member of the faculty. In 1979, he became chief of the radiation oncology branch of the division of cancer treatment at the National Cancer Institute (NCI). From 1992 to 1996, he headed the department of radiation oncology at the University of Texas in Dallas. In 1996, he became vice-chairman and clinical director of the department of radiation oncology at the University of Pennsylvania Medical Center in Philadelphia, the position he currently holds.
- An Interview with Eric Hall, DSc, FASTRO
Dr. Eric Hall obtained his undergraduate degree in physics at University College of London with the intention of pursuing work in high-energy physics, but, for practical reasons, switched to medical physics and went to work at the Churchill Hospital in Oxford where Dr. Frank Ellis was the medical director. He was encouraged to do radiobiology research, so he returned to school at Oxford University where he obtained a doctorate and then accepted a full time research position at Columbia University in New York where he has remained since. In addition to his research contribution to radiation biology, Dr. Hall is admired for his contributions to the teaching of radiobiology to medical students, radiation oncology residents and practicing physicians. For nearly 30 years, Dr. Hall taught a Radiation Biology Refresher Course at the annual ASTRO meetings that was immensely popular. His course was always oversubscribed. He presented radiobiological concepts with clarity and unique humor. Dr. Hall has made many very significant contributions to the scientific literature including three books. In this respect perhaps he is best known for Radiobiology for the Radiologist, one of the most informative, well illustrated and accessible books on the subject. Dr. Hall has now introduced radiobiology teaching on line. Dr. Hall has had enormous impact on the understanding of the basis of radiation therapy.
- An Interview with Florence C.H. Chu, MD, FASTRO
Florence C.H. Chu, MD, FASTRO, was born in Shanghai, China, and graduated medical school from the National College of Shanghai in 1942. Following internship and three years of radiology residency in Shanghai, Dr. Chu and her husband moved to the U.S. where she completed a radiology fellowship at the City Hospital of New York. She moved to Memorial Hospital in New York for a radiation therapy fellowship in 1949 and remained there for 38 years. Dr Chu became chairman of the radiation therapy department at Memorial Sloan Kettering in 1977, the first woman chairman of a radiation oncology department in the U.S. She was instrumental in the early development of electrons for radiation therapy and an early pioneer in breast cancer treatment.
- An interview with Frank Hendrickson, MD, FASTRO
Frank Hendrickson was born in Springfield, Penn. His father was a physician, specializing in ENT and his mother was a homemaker and piano teacher. He was exposed to medicine at an early age since his father had a home office. In 1944, he enrolled in the V12 program of the Navy on an education path at Swarthmore College and attended his father’s alma mater, Jefferson Medical College. After graduation, he started his residency in radiology at Jefferson Medical College. This was interrupted by a two year assignment serving as a general medical officer aboard ship for the Navy. When returning to his residency, he met Ted Eberhard, the first director of radiation therapy at Jefferson Medical College. Dr. Eberhard introduced Dr. Hendrickson to his wife Joan, who worked as a technologist in radiation therapy, and Dr. Eberhard became his mentor in the field of therapeutic radiology. He completed his residency at the University of Pennsylvania due to turmoil in his department. He then went on to a fellowship with the American Cancer Society spending a year in Europe at various therapy centers. Upon his return, Dr. Hendrickson started his career in Chicago at Presbyterian Hospital, and later became the chairman of Rush-Presbyterian St. Luke’s Medical Centre and director of the Fermilab National Accelerator Laboratory. He would go on to serve as ASTRO president in 1978 and study chairman for numerous RTOG trials.
- An Interview with Gerald E. Hanks, MD
Dr. Hanks grew up in Washington State and attended Washington State University. He obtained his medical degree at Washington University in St. Louis, interned at Yale University and trained in radiation therapy at Stanford Medical Center. He was the first trainee in radiation oncology in a training program headed by Dr. Henry Kaplan and sponsored by the National Cancer Institute. After several years in academic medicine, he spent 14 years in private practice in Sacramento, Calif. While in Sacramento he was very active in clinical research with the Radiation Therapy Oncology Group (RTOG) and the Patterns of Care Studies (PCS) established by Dr. Simon Kramer. Dr. Hanks was very active and influential in the development of ASTRO. Dr. Hanks returned to full-time academic practice when he became the head of the radiation oncology department at Fox Chase Cancer Center where he remained until his retirement from active practice.
- An Interview with Giulio D’Angio, MD
Dr. D’Angio was born in Brooklyn, N.Y., attended Columbia University for his undergraduate studies and Harvard University for his medical degree. He served with the U.S. Army Corps in Japan and upon discharge from the Army he spent time in Florence, Italy, studying art and history. Though he considered becoming a pediatric surgeon, he trained in radiology at Boston City Hospital after he totally devoted his career to pediatric oncology. He observed the enhanced effects of the combination of radiotherapy and actinomycin D in Wilms tumors in children and pursued these studies with passion. He founded the National Wilms Tumor Study Group (NWTS). Dr. D’Angio has been a prolific clinical investigator and has published extensively on the outcome and long-term ill effects of multimodality treatment of children with cancer. He has also occupied important administrative positions in radiation oncology.
- An Interview with Herman Suit, MD
Dr. Suit obtained his undergraduate and medical degrees at The University of Houston and Baylor Medical School. While in medical school he became interested in nuclear physics and radiation biology. He was intrigued by the fact that with radiation tumors could be eradicated. He decided to pursue advanced training in radiation therapy and biology. After medical school, Dr. Suit obtained a Doctor of Philosophy degree at Oxford University. He pursued further training at the National Institutes of Health before joining the faculty at The MD Anderson Cancer in Houston. In 1970, Dr. Suit became chair of the department of radiation medicine of Harvard University in Boston where he remains. Dr. Suit has made many contributions to radiation oncology. In the clinical area, he has advanced our understanding of the management of sarcomas and gastrointestinal tumors. In radiation biology, he has had a major role in improving our understanding of oxygenation and fractionation. He has also trained many outstanding radiation oncologists that have gone on to advance our specialty in very significant ways. He played a major role in the development of proton therapy. He was very influential in the development of ASTRO as a separate and independent society that allowed it to become what it is today, the most respected, influential and the largest radiation oncology society in the world.
- An Interview with James Cox, MD, FASTRO
Jim Cox grew up in Dayton, Ohio, and obtained his undergraduate degree from Kenyon College in Gambier, Ohio, and medical degree at the University of Rochester. While in medical school, Jim became very interested in cancer, and this led him to interrupt his medical school education to spend a year at Penrose Cancer Center with Dr. Juan del Regato and later on to return to this institution for radiotherapy training. Jim also trained at the Institute Gustave-Roussy in Paris with Drs. Tubiana and Pierquin, among others. After completing his training and fulfilling his military obligation, Jim held staff and directorship positions at several academic institutions including Georgetown, the Medical College of Wisconsin and Columbia University before becoming physician-in-chief at the University of Texas MD Anderson Cancer Center in 1988. Subsequently Jim was appointed division head and chairman of the department of radiation oncology, a post he held until he relinquished his administrative responsibilities while continuing to be very engaged in his academic, research and clinical activities.
- An Interview with John Archambeau, MD
- An Interview with John F. Fowler, DSc, PhD, FASTRO
An Interview with John F. Fowler, DSc, PhD, FASTRO Question: I am sure that our readers would be very pleased to learn about your early history and the individuals or schools that provoked your interest in physics and math and science. Dr. Fowler: Okay. Well, I was always interested in science, and even be
- An Interview with Joseph R. Castro, MD
Joseph R. Castro, MD, is best known for his pioneering work with proton and heavy ion therapy. He attended undergraduate and medical school at Loyola University in Chicago and trained in radiology and radiation oncology in naval hospitals. He joined Gilbert Fletcher, MD, at MD Anderson Cancer Center in Houston for five years before joining UCSF. He treated over 1,000 patients with helium or heavier ions at Lawrence Berkeley Laboratory in Berkeley, Calif. His research leadership laid the foundation for the subsequent development of particle therapy facilities throughout the world.
- An Interview with Ketayun A. Dinshaw, MB
Ketayun Ardeshir Dinshaw (affectionately called Katy by those who knew her well) was born on November 16, 1943 in Calcutta, India. She graduated with an MB and BS degree from the Christian, Medical College in Vellore and was awarded the D.M.R. T and F.R.C.R. degrees after working at Addenbrooke hospital, Cambridge, U.K.
She joined Tata Memorial Hospital, Mumbai, India in May 1974 and in 1981, was appointed chair of the new department of radiation oncology. With tact and determination, she modernized the department. She instituted a residency program in radiation oncology, headed a radiation oncology in-patient service established multidisciplinary clinics, took charge of the brachytherapy service, and introduced afterloading techniques using iridium, manufactured at her urging by the Bhabha Atomic Research Center. She also initiated India’s first bone marrow transplantation program. Dr. Dinshaw set up ethics and scientific committees to advocate for the patients and enhance the quality of both patient care and research. In 1995, Katy was appointed director of the Tata Memorial Center and served in this position for 13 years until her retirement in 2008.
As a member of the International Atomic Energy Agency, she worked tirelessly to bring Tata Hospital to a position of international recognition. She also served as a consultant for the UICC and the WHO and is a member of the Roll of Honor of these organizations. The government of India awarded her the Padma Shri in 2001. Katy lost her battle with cancer on August 26, 2011.
- An interview with Lawrence Davis, MD, MBA, FASTRO
An interview with Lawrence Davis, MD, MBA, FASTRO
Dr. Phillips: Could you tell us a little bit about where you were born and who your parents were and that kind of thing? Dr. Davis: I was born in the suburb of Pittsburgh, North Braddock, Pennsylvania. It's a really depressed area now because the
- An interview with Lester J. Peters, MD, FASTRO
Professor Lester J. Peters, MD, FASTRO is described as a man of vision, wisdom, integrity and stature. From humble beginnings in rural Australia, professor Peters rose to become a pre-eminent radiation oncologist with international influence. His impressive leadership and career achievements in the United States of America include chair of the department of radiation oncology at UT MD Anderson Cancer Center (1982-1995) and President of ASTRO (1993–1994), and culminated in the coveted ASTRO Gold Medal (awarded in 2003). In 1995, professor Peters returned to Australia where his career continued to evolve: he is well recognized as the “guiding light” of the Australasian radiation oncology community, and has been instrumental in invigorating collaborative research within the region. Professor Peters has gained the respect of radiation oncologists internationally for his tremendous wealth of clinical experience and his passion for research in radiobiology and cancers of the head and neck.